Infinity Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Infinity Pharmaceuticals generated cash of -$42,431,000, which is less than the previous year. Cash used in financing activities reached the amount of $73,000 last year. Net change in cash is therefore -$42,413,000.
Cash Flow
| 2013 | -113.90M | 606K | 5.67M |
|---|---|---|---|
| 2014 | 117.71M | 117.85M | 3.72M |
| 2015 | -83.65M | -37.90M | 2.32M |
| 2016 | -154.35M | 40.32M | -83K |
| 2017 | -36.71M | -4.27M | 1.53M |
| 2018 | -4.71M | 13.10M | 5.61M |
| 2019 | -41.53M | -12.24M | 27.73M |
| 2020 | -35.73M | 14.63M | 27.44M |
| 2021 | -40.61M | 5.48M | 87.10M |
| 2022 | -42.43M | -55K | 73K |
INFI Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 80.88M | 28.90M | 22.57M | 48.61M | 34.60M | 74.06M | 188.17M | 307.40M | 68.11M | 175.74M |
Operating activities | ||||||||||
Net income | -44.36M | -45.26M | -40.49M | -47.05M | -11.25M | -41.83M | -30.10M | -128.37M | -17.41M | -126.78M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 458K | 480K | 483K | 219K | 191K | 1.71M | 3.41M | 2.29M | 1.77M | 1.82M |
Stock-based compensation expense | 3.62M | 2.69M | 1.45M | 2.13M | 3.44M | 6.97M | 13.71M | 14.7M | 12.58M | 12.15M |
| Deferred income tax benefit | 3.62M | 2.69M | 1.45M | 2.13M | 3.44M | 6.97M | 13.71M | 14.7M | 12.58M | 12.15M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -300K | 2.17M | 882K | 1.55M | 2.83M | -17.79M | -20.41M | 10.51M | 6.81M | 3.56M |
Cash generated by operating activities | -42.43M | -40.61M | -35.73M | -41.53M | -4.71M | -36.71M | -154.35M | -83.65M | 117.71M | -113.90M |
Investing activities | ||||||||||
Purchases Of Investments | -16.03M | 0 | -43.00M | -41.86M | -15.68M | -23.98M | -66.50M | -121.45M | -21.78M | -249.76M |
Investments In Property Plant And Equipment | -17K | -11K | -43K | -2.32M | 0 | -43K | -661K | -6.42M | -1.36M | -1.75M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -55K | 5.48M | 14.63M | -12.24M | 13.10M | -4.27M | 40.32M | -37.90M | 117.85M | 606K |
Financing activities | ||||||||||
Common Stock Issued | 73K | 87.10M | 7.86M | 112K | 9.61M | 146K | 332K | 2.83M | 3.88M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 18K | 964K | 836K | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | -4M | 0 | -415K | 0 | 0 | 0 |
Cash used in financing activities | 73K | 87.10M | 27.44M | 27.73M | 5.61M | 1.53M | -83K | 2.32M | 3.72M | 5.67M |
Net Change In Cash | -42.41M | 51.97M | 6.33M | -26.04M | 14.00M | -39.45M | -114.11M | -119.23M | 239.29M | -107.62M |
Cash at end of period | 38.47M | 80.88M | 28.90M | 22.57M | 48.61M | 34.60M | 74.06M | 188.17M | 307.40M | 68.11M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |